This is the point

Mammotome is committed to advancing technology to help clinicians accurately diagnose breast disease, such as breast cancer, through minimally invasive procedures.

As the global market leader in vacuum-assisted breast biopsy, Mammotome has offered physicians and women a wide range of options and diagnostic tools since 1995.

The Mammotome^® Biopsy System is a complete system for breast tissue sampling and management. Compatible with multiple imaging modalities, the Mammotome Biopsy System enables breast biopsy to be performed under stereotactic x-ray, ultrasound, MRI or molecular imaging guidance. Mammotome offers a full array of tissue markers to mark the biopsy site for follow-up observations.

With the Mammotome Biopsy System, clinicians can achieve diagnostic confidence using a less invasive approach that offers women faster recovery, less scarring and lower costs of care as compared to open procedures.

More than 3 million women worldwide have had an image-guided, minimally invasive breast biopsy using the Mammotome Biopsy System.

More physicians have relied on Mammotome to help them reach the proper diagnosis and treatment for their patients.

And, more women's lives – and the people who love them – have been enhanced with an accurate diagnosis. Which is, ultimately, the point.

Share this site with a friend.